Hervé Brailly, CEO, is invited to the panel discussion "French Public Markets – Breakthrough Technologies Panel".
Zurich,Switzerland
More info
Innate Pharma announces that it will participate to the MidCap Event on 21-22 September, 2009.
September 17, 2009
- Hervé Brailly, CEO of Innate Pharma, and Stéphane Boissel, Executive Vice President and Chief Financial Officer, will present the Company to the investors during the MIDCAP event in Paris
- Upon the occasion of the announcement of interim clinical results for IPH 1101 at the ESMO congress on Monday 21, the Company will host a conference call at 2:30pm on that same day (Details to connect to this call will be communicated on monday)
- Hervé Brailly, CEO of Innate Pharma, and Stéphane Boissel, Executive Vice President and Chief Financial Officer, will present the Company to the investors during the MIDCAP event in Paris
- Upon the occasion of the announcement of interim clinical results for IPH 1101 at the ESMO congress on Monday 21, the Company will host a conference call at 2:30pm on that same day (Details to connect to this call will be communicated on monday)
| Download Area |
|---|
| PR in english |
| CP en français |